By Kelly Cloonan
Siemens has agreed to acquire Dotmatics, a life-science research-and-development software company, for $5.1 billion, the companies said Wednesday.
The deal will be financed primarily through the sale of shares in listed companies, including Siemens Healthineers, Siemens said.
Dotmatics extends Siemens's artificial-intelligence-powered product-lifecycle-management portfolio into life sciences and increases the company's total addressable market in industrial software by $11 billion.
The deal aligns with the Munich company's aims to accelerate innovation across industries.
"Artificial Intelligence has emerged as a transformative force across various industries, and its application in Life Sciences is becoming increasingly important," Siemens Chief Executive Roland Busch said.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 02, 2025 14:52 ET (18:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.